A recent report showed that SMYD3 was also over-expressed in BC and facilitated BC progression [16], however, it is currently unclear how SMYD3 accomplishes its ends in BC, which is the key issue addressed in the present study. The gene discussed is SMYD3; the disease is breast cancer.